CAPRI HOLDINGS LTD (CPRI)

VGG1890L1076 - Common Stock

21.89  +1.61 (+7.94%)

After market: 21.71 -0.18 (-0.82%)

Fundamental Rating

3

Taking everything into account, CPRI scores 3 out of 10 in our fundamental rating. CPRI was compared to 49 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of CPRI have multiple concerns. CPRI has a valuation in line with the averages, but it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

CPRI had positive earnings in the past year.
In the past year CPRI had a positive cash flow from operations.
In multiple years CPRI reported negative net income over the last 5 years.
Each year in the past 5 years CPRI had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -5.26%, CPRI is doing worse than 72.92% of the companies in the same industry.
CPRI has a Return On Equity of -24.06%. This is in the lower half of the industry: CPRI underperforms 72.92% of its industry peers.
CPRI has a worse Return On Invested Capital (2.65%) than 64.58% of its industry peers.
CPRI had an Average Return On Invested Capital over the past 3 years of 10.00%. This is in line with the industry average of 11.25%.
The 3 year average ROIC (10.00%) for CPRI is well above the current ROIC(2.65%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -5.26%
ROE -24.06%
ROIC 2.65%
ROA(3y)5.34%
ROA(5y)2.47%
ROE(3y)17.04%
ROE(5y)7.59%
ROIC(3y)10%
ROIC(5y)8.43%

1.3 Margins

CPRI has a worse Operating Margin (3.50%) than 62.50% of its industry peers.
In the last couple of years the Operating Margin of CPRI has declined.
With an excellent Gross Margin value of 64.18%, CPRI belongs to the best of the industry, outperforming 85.42% of the companies in the same industry.
CPRI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 64.18%
OM growth 3Y-10.43%
OM growth 5Y-15.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y1.24%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPRI is still creating some value.
Compared to 1 year ago, CPRI has less shares outstanding
CPRI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CPRI is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.17 indicates that CPRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.17, CPRI is not doing good in the industry: 72.92% of the companies in the same industry are doing better.
CPRI has a debt to FCF ratio of 4.62. This is a neutral value as CPRI would need 4.62 years to pay back of all of its debts.
With a Debt to FCF ratio value of 4.62, CPRI perfoms like the industry average, outperforming 45.83% of the companies in the same industry.
CPRI has a Debt/Equity ratio of 0.83. This is a neutral value indicating CPRI is somewhat dependend on debt financing.
The Debt to Equity ratio of CPRI (0.83) is worse than 72.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 4.62
Altman-Z 2.17
ROIC/WACC0.33
WACC8.15%

2.3 Liquidity

CPRI has a Current Ratio of 0.93. This is a bad value and indicates that CPRI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.93, CPRI is not doing good in the industry: 93.75% of the companies in the same industry are doing better.
CPRI has a Quick Ratio of 0.93. This is a bad value and indicates that CPRI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CPRI (0.38) is worse than 97.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.38

1

3. Growth

3.1 Past

CPRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.64%.
CPRI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.86% yearly.
Looking at the last year, CPRI shows a very negative growth in Revenue. The Revenue has decreased by -10.64% in the last year.
The Revenue has been decreasing by -0.26% on average over the past years.
EPS 1Y (TTM)-50.64%
EPS 3Y22.68%
EPS 5Y-6.86%
EPS Q2Q%-42.48%
Revenue 1Y (TTM)-10.64%
Revenue growth 3Y8.39%
Revenue growth 5Y-0.26%
Sales Q2Q%-16.42%

3.2 Future

The Earnings Per Share is expected to grow by 10.08% on average over the next years. This is quite good.
The Revenue is expected to decrease by -0.67% on average over the next years.
EPS Next Y-53.28%
EPS Next 2Y-24.31%
EPS Next 3Y-11.73%
EPS Next 5Y10.08%
Revenue Next Year-13.52%
Revenue Next 2Y-6.65%
Revenue Next 3Y-3.57%
Revenue Next 5Y-0.67%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.48, the valuation of CPRI can be described as very reasonable.
Based on the Price/Earnings ratio, CPRI is valued cheaper than 91.67% of the companies in the same industry.
CPRI is valuated cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.95 indicates a reasonable valuation of CPRI.
Based on the Price/Forward Earnings ratio, CPRI is valued cheaper than 87.50% of the companies in the same industry.
CPRI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.73.
Industry RankSector Rank
PE 9.48
Fwd PE 10.95

4.2 Price Multiples

CPRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CPRI is cheaper than 68.75% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CPRI is valued cheaply inside the industry as 89.58% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.97
EV/EBITDA 10.9

4.3 Compensation for Growth

A cheap valuation may be justified as CPRI's earnings are expected to decrease with -11.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.31%
EPS Next 3Y-11.73%

0

5. Dividend

5.1 Amount

CPRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAPRI HOLDINGS LTD

NYSE:CPRI (1/6/2025, 4:38:05 PM)

After market: 21.71 -0.18 (-0.82%)

21.89

+1.61 (+7.94%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners85.46%
Inst Owner Change0%
Ins Owners2.31%
Ins Owner Change1.7%
Market Cap2.58B
Analysts69.57
Price Target25 (14.21%)
Short Float %7.93%
Short Ratio1.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-54.31%
Min EPS beat(2)-93.35%
Max EPS beat(2)-15.28%
EPS beat(4)0
Avg EPS beat(4)-44.06%
Min EPS beat(4)-93.35%
Max EPS beat(4)-15.28%
EPS beat(8)2
Avg EPS beat(8)-27.32%
EPS beat(12)6
Avg EPS beat(12)-12.2%
EPS beat(16)10
Avg EPS beat(16)125.95%
Revenue beat(2)0
Avg Revenue beat(2)-9.9%
Min Revenue beat(2)-10.23%
Max Revenue beat(2)-9.58%
Revenue beat(4)0
Avg Revenue beat(4)-8.17%
Min Revenue beat(4)-10.23%
Max Revenue beat(4)-5.43%
Revenue beat(8)2
Avg Revenue beat(8)-4.85%
Revenue beat(12)5
Avg Revenue beat(12)-2.12%
Revenue beat(16)8
Avg Revenue beat(16)-0.29%
PT rev (1m)5.31%
PT rev (3m)-44.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-44.75%
EPS NY rev (1m)-2.77%
EPS NY rev (3m)-31.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.37%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-4.93%
Valuation
Industry RankSector Rank
PE 9.48
Fwd PE 10.95
P/S 0.54
P/FCF 6.97
P/OCF 4.78
P/B 1.74
P/tB N/A
EV/EBITDA 10.9
EPS(TTM)2.31
EY10.55%
EPS(NY)2
Fwd EY9.13%
FCF(TTM)3.14
FCFY14.35%
OCF(TTM)4.58
OCFY20.9%
SpS40.72
BVpS12.6
TBVpS-9.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.26%
ROE -24.06%
ROCE 3.36%
ROIC 2.65%
ROICexc 2.75%
ROICexgc 5.9%
OM 3.5%
PM (TTM) N/A
GM 64.18%
FCFM 7.71%
ROA(3y)5.34%
ROA(5y)2.47%
ROE(3y)17.04%
ROE(5y)7.59%
ROIC(3y)10%
ROIC(5y)8.43%
ROICexc(3y)10.37%
ROICexc(5y)8.83%
ROICexgc(3y)23.03%
ROICexgc(5y)20.34%
ROCE(3y)12.66%
ROCE(5y)10.67%
ROICexcg growth 3Y-5.18%
ROICexcg growth 5Y-29.13%
ROICexc growth 3Y2.41%
ROICexc growth 5Y-15.56%
OM growth 3Y-10.43%
OM growth 5Y-15.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y1.24%
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 4.62
Debt/EBITDA 3.45
Cap/Depr 88.48%
Cap/Sales 3.52%
Interest Coverage 1.89
Cash Conversion 150.14%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.38
Altman-Z 2.17
F-Score4
WACC8.15%
ROIC/WACC0.33
Cap/Depr(3y)98.22%
Cap/Depr(5y)87.32%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.64%
EPS 3Y22.68%
EPS 5Y-6.86%
EPS Q2Q%-42.48%
EPS Next Y-53.28%
EPS Next 2Y-24.31%
EPS Next 3Y-11.73%
EPS Next 5Y10.08%
Revenue 1Y (TTM)-10.64%
Revenue growth 3Y8.39%
Revenue growth 5Y-0.26%
Sales Q2Q%-16.42%
Revenue Next Year-13.52%
Revenue Next 2Y-6.65%
Revenue Next 3Y-3.57%
Revenue Next 5Y-0.67%
EBIT growth 1Y-67.69%
EBIT growth 3Y-2.91%
EBIT growth 5Y-16.05%
EBIT Next Year-26.87%
EBIT Next 3Y0.62%
EBIT Next 5Y10.83%
FCF growth 1Y107.87%
FCF growth 3Y-38.38%
FCF growth 5Y-25.13%
OCF growth 1Y55.33%
OCF growth 3Y-20.89%
OCF growth 5Y-14.94%